CVS Health

Company

Last mentioned: Mar 24, 2026

Timeline

  1. Supreme Court Ruling

    SCOTUS maintains access to mifepristone by dismissing a challenge to FDA's rules on procedural grounds.

  2. Pharmacy Certification

    FDA updates REMS to allow retail pharmacies to dispense mifepristone upon certification.

  3. Mail-Order Authorization

    FDA permanently removes the requirement for in-person dispensing, allowing for telehealth and mail delivery.

  4. Protocol Expansion

    FDA extends usage window to 10 weeks and reduces required office visits from three to one.

  5. Initial FDA Approval

    FDA approves mifepristone for medical termination of pregnancy through seven weeks.

Stories mentioning CVS Health 1

About CVS Health coverage

This page surfaces every story mentioning CVS Health across our healthcare coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.

Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running healthcare beat. Cross-entity comparisons live on our compare view.

What you seeWhat it tells you
Story countNumber of distinct stories where CVS Health was a primary or referenced actor.
Recency clusteringWhether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distributionAggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche linksWhen the same entity surfaces in our sibling networks, we link to those views to enrich context.